CIITA-related block of HLA class II expression, upregulation of HLA class I, and heterogeneous expression of immune checkpoints in hepatocarcinomas: implications for new therapeutic approaches

Ítems similars

• CIITA-Driven MHC Class II Expressing Tumor Cells as Antigen Presenting Cell Performers: Toward the Construction of an Optimal Anti-tumor Vaccine
  per: Roberto S. Accolla, et al.
  Publicat: (2019-07-01)
• CIITA-Driven MHC Class II Expressing Tumor Cells as Antigen Presenting Cell Performers: Toward the Construction of an Optimal Anti-tumor Vaccine
  per: Accolla, Roberto S., et al.
  Publicat: (2019)
• CIITA-driven MHC class II expressing tumor cells can efficiently prime naive CD4(+) TH cells in vivo and vaccinate the host against parental MHC-II-negative tumor cells
  per: Bou Nasser Eddine, Farah, et al.
  Publicat: (2016)
• Restriction factors in human retrovirus infections and the unprecedented case of CIITA as link of intrinsic and adaptive immunity against HTLV-1
  per: Forlani, Greta, et al.
  Publicat: (2019)
• Tumor Immunology meets…Immunology: Modified cancer cells as professional APC for priming naïve tumor-specific CD4+ T cells
  per: Bou Nasser Eddine, Farah, et al.
  Publicat: (2017)